Glaucoma surgery devices market was valued at $2.10 billion in 2025 and is expected to reach $4.30 billion by 2035, registering a CAGR of 7.4% during 2026–2035. Market growth is primarily driven by the rising global prevalence of glaucoma, coupled with continuous advancements in surgical technologies such as micro-stent devices. Additionally, the increasing shift toward minimally invasive glaucoma surgery (MIGS) is transforming the treatment landscape by offering safer procedures, reduced complications, and faster patient recovery. These benefits are encouraging both patients and healthcare providers to prefer surgical interventions over traditional treatment approaches, thereby accelerating market expansion.
The industry is also experiencing significant innovation in micro-stent technology and laser-based surgical systems, which enable more precise and effective intraocular pressure management. As a result, hospitals and ophthalmic clinics are increasingly adopting these advanced devices due to their improved safety, efficiency, and clinical outcomes. A notable development occurred in December 2025, when Iridex Corporation reported the publication of an independent clinical study demonstrating that transscleral laser retreatment using its MicroPulse technology effectively and safely reduced intraocular pressure in glaucoma patients. The study further highlighted the repeatability and real-world clinical value of non-incisional laser therapies, reinforcing the growing demand for advanced laser-based surgical devices. Such developments underscore the intensifying competition and ongoing innovation in the market, with manufacturers focusing on product advancements and expanding their geographic presence.
Tiny Implants, Big Impact: MIGS Devices Redefine Glaucoma Care
Minimally invasive glaucoma surgery (MIGS) devices have emerged as the leading sub-segment within the glaucoma surgery devices market, capturing the largest share due to the growing preference for less invasive treatment options. These devices offer significant advantages, including reduced surgical risk, faster recovery, and improved patient outcomes compared to conventional procedures. The increasing adoption of MIGS is being driven by both patients and clinicians seeking safer and more efficient solutions for managing intraocular pressure. In January 2026, Alcon highlighted the strong clinical and scientific profile of its Hydrus Microstent, a MIGS device specifically designed to lower intraocular pressure in patients with primary open-angle glaucoma. The company emphasized robust clinical evidence and peer-reviewed data supporting its effectiveness and safety. This development reinforces the expanding role of advanced MIGS technologies in modern glaucoma treatment. As innovation continues, MIGS devices are expected to remain a key growth driver in the global glaucoma surgery devices market.
Precision Light Therapy Redefines Glaucoma Treatment Landscape
Laser-based surgery represents a non-invasive approach for treating glaucoma, utilizing advanced laser systems to lower intraocular pressure by enhancing fluid drainage or reducing its production within the eye. Key procedures such as Selective Laser Trabeculoplasty (SLT), now widely recognized as a first-line therapy, and Laser Peripheral Iridotomy (LPI) are gaining strong clinical acceptance. These technologies are increasingly valued for their ability to reduce patient dependence on long-term eye drop medications while improving treatment compliance. As a result, laser-based glaucoma interventions are emerging as a rapidly growing segment within the market. In February 2025, Alcon announced the U.S. launch of its Voyager DSLT device, the first automated Direct Selective Laser Trabeculoplasty system designed to enhance procedural efficiency and consistency. This innovation is expected to broaden access to advanced laser therapies and significantly accelerate the adoption of non-invasive glaucoma treatment solutions in clinical practice.
Market Segmentation
Powering Precision Eye Care: Hospitals Lead the Charge in Advanced Glaucoma Surgery
Hospitals continue to dominate the glaucoma surgery devices market due to their capability to manage a high volume of complex surgical procedures supported by advanced infrastructure and highly skilled ophthalmic surgeons. Equipped with state-of-the-art surgical and laser technologies, hospitals are well-positioned to treat both early-stage and advanced glaucoma cases with greater precision and efficiency. Their ability to integrate innovative solutions such as minimally invasive glaucoma surgery (MIGS) and imaging-guided systems further strengthens their leadership in this segment. In November 2025, the Cleveland Clinic inaugurated the Jeffrey and Patricia Cole Pavilion at the Cole Eye Institute, a modern 150,000-square-foot facility designed to expand surgical and procedural capacity for advanced ophthalmic treatments, including glaucoma surgery. Since its earlier opening in February 2025, the institute has already treated tens of thousands of patients and conducted thousands of complex eye surgeries. This expansion highlights the critical role hospitals play in driving the adoption of advanced glaucoma surgery devices while improving patient outcomes and access to specialized care.
The global glaucoma surgery devices market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America is the leading region in the market
North America leads the glaucoma surgery devices market, driven by the widespread adoption of minimally invasive glaucoma surgery (MIGS) devices and well-established reimbursement frameworks that support advanced ophthalmic procedures. The region benefits from strong healthcare infrastructure, high awareness levels, and early adoption of innovative surgical technologies. In March 2026, Bausch + Lomb reported positive 24-month U.S. clinical trial outcomes for its ELIOS System, an implant-free excimer laser-based glaucoma surgery platform. The study demonstrated a significant reduction in intraocular pressure among patients with open-angle glaucoma. These results highlight the growing clinical acceptance of non-implant, minimally invasive approaches. Such advancements are reinforcing the region’s leadership and accelerating innovation in glaucoma surgical devices.
Market Players Outlook
The major companies operating in the global Glaucoma Surgery Devices market include Johnson & Johnson Vision, AbbVie, Alcon, Bausch + Lomb, and Santen Pharmaceutical, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their business and drive innovative product development, maintaining their market positioning.
Recent Development
The Report Covers
1. Global Glaucoma Surgery Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
3. Global Glaucoma Drainage Devices (GDD) Market Research and Analysis By Region, 2025-2035 ($ Million)
4. Global Laser Glaucoma Surgery Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
5. Global Traditional Glaucoma Surgery Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
6. Global Glaucoma Surgery Devices Market Research and Analysis By Surgical Method, 2025-2035 ($ Million)
7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
8. Global Laser-based Glaucoma Surgery Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
9. Global Conventional Incisional Glaucoma Surgery Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
10. Global Glaucoma Surgery Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
11. Global Glaucoma Surgery Devices For Hospitals Market Research and Analysis By Region, 2025-2035 ($ Million)
12. Global Glaucoma Surgery Devices For Ophthalmic Clinics Market Research and Analysis By Region, 2025-2035 ($ Million)
13. Global Glaucoma Surgery Devices For Ambulatory Surgical Centers (ASCs) Market Research and Analysis By Region, 2025-2035 ($ Million)
14. Global Glaucoma Surgery Devices Global Glaucoma Surgery Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
15. North American Glaucoma Surgery Devices Market Research and Analysis By Country, 2025-2035 ($ Million)
16. North American Glaucoma Surgery Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
17. North American Glaucoma Surgery Devices Market Research and Analysis By Surgical Method, 2025-2035 ($ Million)
18. North American Glaucoma Surgery Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
19. European Glaucoma Surgery Devices Market Research and Analysis By Country, 2025-2035 ($ Million)
20. European Glaucoma Surgery Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
21. European Glaucoma Surgery Devices Market Research and Analysis By Surgical Method, 2025-2035 ($ Million)
22. European Glaucoma Surgery Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
23. Asia-Pacific Glaucoma Surgery Devices Market Research and Analysis By Country, 2025-2035 ($ Million)
24. Asia-Pacific Glaucoma Surgery Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
25. Asia-Pacific Glaucoma Surgery Devices Market Research and Analysis By Surgical Method, 2025-2035 ($ Million)
26. Asia-Pacific Glaucoma Surgery Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
27. Rest of the World Glaucoma Surgery Devices Market Research and Analysis By Country, 2025-2035 ($ Million)
28. Rest of the World Glaucoma Surgery Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
29. Rest of the World Glaucoma Surgery Devices Market Research and Analysis By Surgical Method, 2025-2035 ($ Million)
30. Rest of the World Glaucoma Surgery Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
1. Global Glaucoma Surgery Devices Market Research and Analysis By Product Type, 2025 Vs 2035 ($ Million)
2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
3. Global Glaucoma Drainage Devices (GDD) Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
4. Global Laser Glaucoma Surgery Devices Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
5. Global Traditional Glaucoma Surgery Devices Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
6. Global Glaucoma Surgery Devices Market Research and Analysis By Surgical Method, 2025 Vs 2035 ($ Million)
7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
8. Global Laser-based Glaucoma Surgery Devices Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
9. Global Conventional Incisional Glaucoma Surgery Devices Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
10. Global Glaucoma Surgery Devices Market Research and Analysis By End User, 2025 Vs 2035 ($ Million)
11. Global Glaucoma Surgery Devices For Hospitals Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
12. Global Glaucoma Surgery Devices For Ophthalmic Clinics Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
13. Global Glaucoma Surgery Devices For Ambulatory Surgical Centers (ASCs) Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
14. US Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
15. Canada Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
16. UK Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
17. France Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
18. Germany Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
19. Italy Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
20. Spain Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
21. Russia Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
22. Rest of Europe Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
23. India Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
24. China Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
25. Japan Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
26. South Korea Glaucoma Surgery Devices, 2025-2035 ($ Million)
27. Australia and New Zealand Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
28. ASEAN Economies GLAUCOMA SURGERY DEVICES Market Size, 2025-2035 ($ Million)
29. Rest of Asia-Pacific Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
30. Latin America Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)
31. Middle East and Africa Glaucoma Surgery Devices Market Size, 2025-2035 ($ Million)